thiamorpholine has been researched along with Trypanosomiasis, African in 1 studies
*Trypanosomiasis, African: A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces African sleeping sickness. Nagana is a rapidly fatal trypanosomiasis of horses and other animals. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basta, A; Biancofiore, I; Ciammaichella, A; D'Amico, M; Ferrigno, F; Fini, I; Gennari, N; Graziani, R; Harper, S; Nardi, V; Ontoria, JM; Paonessa, G; Ponzi, S; Summa, V; Vittoria Orsale, M | 1 |
1 other study(ies) available for thiamorpholine and Trypanosomiasis, African
| Article | Year |
|---|---|
Optimization of 2-(1H-imidazo-2-yl)piperazines series of Trypanosoma brucei growth inhibitors as potential treatment for the second stage of HAT.
Topics: Cell Survival; Drug Evaluation, Preclinical; Growth Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Isomerism; Morpholines; Piperazines; Quinolines; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2020 |